Maternal EED and Aflatoxin Birth Outcomes Study Uganda
Association Among Maternal Environmental Enteric Dysfunction, Aflatoxin Exposure, and Birth Outcomes: A Prospective Cohort Study in Mukono, Uganda
Sponsor: Harvard School of Public Health (HSPH)
Listed as NCT03429257, this observational or N/A phase trial focuses on Aflatoxins Toxicity and Birth Weight and remains completed. Sponsored by Harvard School of Public Health (HSPH), it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Mar 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2018 — Nov 2020 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harvard School of Public Health (HSPH)
- Tufts University
- United States Agency for International Development (USAID)
For direct contact, visit the study record on ClinicalTrials.gov .